Amioka, K.; Kawaoka, T.; Kosaka, M.; Johira, Y.; Shirane, Y.; Miura, R.; Murakami, S.; Yano, S.; Naruto, K.; Ando, Y.;
et al. Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma. Cancers 2022, 14, 320.
https://doi.org/10.3390/cancers14020320
AMA Style
Amioka K, Kawaoka T, Kosaka M, Johira Y, Shirane Y, Miura R, Murakami S, Yano S, Naruto K, Ando Y,
et al. Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma. Cancers. 2022; 14(2):320.
https://doi.org/10.3390/cancers14020320
Chicago/Turabian Style
Amioka, Kei, Tomokazu Kawaoka, Masanari Kosaka, Yusuke Johira, Yuki Shirane, Ryoichi Miura, Serami Murakami, Shigeki Yano, Kensuke Naruto, Yuwa Ando,
and et al. 2022. "Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma" Cancers 14, no. 2: 320.
https://doi.org/10.3390/cancers14020320
APA Style
Amioka, K., Kawaoka, T., Kosaka, M., Johira, Y., Shirane, Y., Miura, R., Murakami, S., Yano, S., Naruto, K., Ando, Y., Kosaka, Y., Fujii, Y., Kodama, K., Uchikawa, S., Fujino, H., Ono, A., Nakahara, T., Murakami, E., Okamoto, W.,
... Aikata, H.
(2022). Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma. Cancers, 14(2), 320.
https://doi.org/10.3390/cancers14020320